Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Welcome, Guest.

Go to Main Navigation

Industry Trends

Showing 41 - 50 of 53 posts
Mar 12, 2014

Last year, Scientist announced our winners for the Rare Disease Challenge, as part of our efforts to raise awareness for rare diseases. We know how...

Mar 10, 2014

We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug...

Feb 26, 2014

Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...

Feb 18, 2014

Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope...

Feb 11, 2014

Three outstanding examples for fragment-based drug discovery A good example for the reliability of the fragment-based screening method is...

Feb 4, 2014

Illumina recently announced the $1000 solution for the sequencing of the human genome in the form of its new instrument, the HiSeqX. This system...

Jan 23, 2014

This is Part 3 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 2). Big Data — the vast...

Jan 16, 2014

This is Part 2 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 3). Recent medical...

Jan 14, 2014

So how does the pharmaceutical industry restore its jaded public image? The answer is by changing itself from within, by paying more than just lip...

Jan 9, 2014

This is Part 1 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 2 and Part 3). Medical research and...